Daré Bioscience (DARE) Stock Statistics & Valuation Metrics

Daré Bioscience has a market cap or net worth of $27.50M. The enterprise value is $24.27M.

Daré Bioscience has 13,479,502 shares outstanding. The number of shares has decreased by -2.65% in one year.

Daré Bioscience’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is -2253.27%.

The current PE Ratio of Daré Bioscience is ―. Daré Bioscience’s PEG ratio is ―.

In the last 12 months, Daré Bioscience had revenue of 9.78K and earned -4.05M in profits. Earnings per share was -0.48.

In the last 12 months, operating cash flow was -11.59M and capital expenditures -284.46K, giving a free cash flow of -11.87M billion.

Daré Bioscience pays an annual dividend of ―, resulting in a dividend yield of ―

Daré Bioscience upcoming earnings date is Nov 6, 2025, TBA (Confirmed).

Daré Bioscience as a current ratio of 0.85, with Debt / Equity ratio of -37.36%

In the past 12 months, Daré Bioscience has paid 0.00 in taxes.

Daré Bioscience EV to EBITDA ratio is -0.52, with an EV/FCF ratio of 2.51.

Daré Bioscience has $5.04M in cash and marketable securities with $3.57M in debt, giving a net cash position of -$2.00M billion.

Gross margin is -54889.98%, with operating margin of -239687.24%, and net profit margin of -41435.00%.

The average price target for Daré Bioscience is $11.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy